Step 3 P-treatment: Drug Class Selection. Pharmacological and Non- Pharmacological Management Dyslipidemia drug therapyLifestyle modification Smoking.

Slides:



Advertisements
Similar presentations
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia N Engl J Med Mar 11;362(10): Paul W. Ladenson, M.D., Jens D.
Advertisements

Agents Used in the Treatment of Hyperlipidemia
Drugs in dyslipidaemias
Common Questions in Lipids 2010 Mehul Bhatt, MD Athens Heart Center.
Drugs and Dyslipidemias (statins and other lipid and atherosclerosis-modifying drugs) October 18, 2006 Frank F. Vincenzi.
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
Dyslipidemia/Lipid management in Diabetes. M ECHANISMS R ELATING I NSULIN R ESISTANCE AND D YSLIPIDEMIA  TG  Apo B  VLDL (hepatic lipase) Kidney (CETP)CEHDL.
Treatment of Dyslipidemia SDPI CGP Healthy Heart Project March 8, 2006.
Cholesterol.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 50 Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol.
TM © 1999 Professional Postgraduate Services ® S: Total Mortality Reduction in a Subgroup of Patients With Diabetes Proportion.
DYSLIPIDEMIA IN ADULTS WITH DIABETES* 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada *Updated in Leiter.
ANTILIPEMICS LILLEY, READING & WORKBOOK: CHAP 28 Cardiovascular System.
Antidyslipidemic drugs
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 29 Antilipemic Drugs.
The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Kirk Mykytyn, Ph.D. Department of Pharmacology
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.
Management of Obesity and Dyslipidemia Presented by : Faisal Hassan Hussain.
Antidislipidemic drugs ( Summary ) © Dr Ivan Lambev, PhD Medical University of Sofia, Faculty of Medicine Department.
ANTIHYPERLIPIDEMIC DRUGS
Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.
Antihyperlipidemia.
Slide 1 EZT 2002-W-6022-SS Ezetimibe Co-administered with Statins: Efficacy and Tolerability Copyright © 2003 MSP Singapore Company, LLC. All rights reserved.
SECONDARY PREVENTIONS Jaimon Stucki MS-1 PSCOM. Blood Draw.
Slide 1 Downloaded from Ezetimibe Factorial Coadministration Studies.
Slide 1 EZT 2003-W SS Mechanism of Action and Pharmacology of Ezetimibe Copyright © 2003 MSP Singapore Company, LLC. All rights reserved.
Management & Medications  Diet, weight loss and drug therapy are the mainstay of treatment, while exercise training is used as adjunctive therapy  Lipid-lowering.
Antihyperlipidemic drugs The clinically important lipoproteins are LDL low density lipoprotein, VLDL very low density lipoprotein, HDL high density lipoprotein.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Jiří Slíva, M.D. statins (inhibitors of HMG-CoA reductase) fibrates anion - exchange resins nicotinic acid group.
HYPERLIPIDEMIA Applied Therapeutics Dr. Riyadh Mustafa Al-Salih.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Antilipemic Drugs.
HLD Tx & AHA/ACC Guidelines
Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.
Management of Hyperlipoprotinaemia
1 HYPOLIPIDAEMICS or LIPID LOWERING DRUGS. 2 Hypolipidaemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
 Define cholesterol.  Discuss the purpose of lipoproteins.  Distinguish between LDL and HDL.
50 Drugs that Help Normalize Cholesterol & Triglyceride Levels
Overview Lipoprotein metabolism Digestive lipid metabolism
Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.
Drugs Used in Hyperlipidemia
Antihyperlipidemic Drugs
أبدا لم يفت الاوان لكي تبدأ
Drugs for Lipid Disorders
Anti-Hypercholesterolemic Agents
By: Dr Israa Omar MBBS, MRCP, MSc pharmacology
Formative Test.
Intensive Statin Recommendations
Applied Therapeutics Dr. Riyadh Mustafa Al-Salih
Anti-Hypercholesterolemic Agents
PHARMACOTHERAPY OF HYPERLIPIDEMIAS
Biosynthesis and Metabolism of Cholesterol
Antilipidaemic agents
Antihyperlipidemic Drugs
Cardiovascular System
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Section 7: Aggressive vs moderate approach to lipid lowering
Major classes of drugs to reduce lipids
Opening a New Lipid “Apo-thecary”: Incorporating Apolipoproteins as Potential Risk Factors and Treatment Targets to Reduce Cardiovascular Risk  Terry.
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Section 6: Update on lipid treatment guidelines
Specific Dyslipidemias: Very High LDL Cholesterol (>190 mg/dL)
Presentation transcript:

Step 3 P-treatment: Drug Class Selection

Pharmacological and Non- Pharmacological Management Dyslipidemia drug therapyLifestyle modification Smoking cessation Weight management Regular physical exercise Adequate blood pressure monitoring and control Dietary management: low fat, low cholesterol

Drug Classes Statins Nicotinic Acid Fibric Acid Derivatives Bile-Acid Binding Resins Ezetimibe

Statins MOA – HMG-CoA reductase inhibitor : reduces hepatic cholesterol synthesis Efficacy (++++) – Significant reduction of LDL (up to 35%) – Increase in HDL (5-10 %) – Decreased triglyceride levels – Level of evidence: meta analysis

Statins - Continued Safety: (+++) – Risk of myositis if taken in combination with fibrates or niacin – Not recommended in those with hepatic derangements Suitability (+++) – Primary concern is LDL lowering – Ease of administration: oral preparation, once a day. Cost: (++++) – Afordel: Php / month at 10 mg/day

Nicotinic Acid MOA – Reduces production of VLDL: secondary reduction in LDL and increase in HDL Efficacy (+++) – Significant increase in HDL (~30%) – Decrease in LDL (~20%) – Significant decrease in Triglycerides – Long experience: reduction in coronary events and mortality

Safety (++) – Intolerance is common with full doses – “hot flashes” and pruritus – Precaution if used with statins Suitability (++) – Suboptimal LDL lowering if not at full dose Cost (+++) – Niaspan: Php 555 pesos / month at 500 mg/day Nicotinic Acid- Continued

Fibric Acid Derivatives MOA – PPAR-alpha agonist – Reduced Apolipoprotein C-III synthesis: increased lipoprotein lipase activity: increased VLDL clearance Efficacy (++) – Significantly reduces triglycerides (~40%) – Increase HDL (~20%) – Reduce LDL (~15%) – Reduced CHD rates among hypercholesterolemics

Safety (++) – Risk of developing cholelithiasis, hepatitis, and myositis Suitability (++) – Most benefit is seen among those with hypertriglyceridemia and low HDL cholesterol – Taken twice a day Cost (++) – Nubrex: Php 1072 / month at 200 mg/day Fibric Acid Derivatives- Continued

Bile Acid Binding Resins MOA – Reduces enterohepatic circulation of bile acids – Increases hepatic production of bile acids, consuming hepatic cholesterol Efficacy (+++) – Reducton in LDL (~20%) – Increase in triglycerides – No effect to HDL – Reduced incidence of coronary events in studies

Safety (+++) – Interferes with absorption of fat-soluble vitamins – Caution with warfarin Suitability (++) – Primary effect targets LDL – Monotherapy may be insufficient – Doses need to be divided Cost N/A – Cost abroad is greater than that of statins BAB Resins- Continued

Ezetimibe MOA – Inhibits a cholesterol transporter in the intestine, reducing enteric absorption Efficacy (+++) – Reduces LDL (~20%) – No significant effect on HDL and Triglycerides

Safety (++) – Can be used in combination with statins Suitability (++) – Specific for LDL reduction – Monotherapy may be insufficient – Once a day dosing Cost (+) – Ezetrol: Php 3000/month at 10 mg/day Ezetimibe- Continued

Summary Drug ClassEfficacySafetySuitabilityCost Statins Nicotinic Acid Fibrates++ Resins+++++ N/A Ezetimibe Therefore, considering the efficacy, safety and suitability and the cost of the available treatment options, STATINS is the most preferred drug class of choice. Statins are composed of several kinds, and thus we discuss this further.

STATINS Drug class of most benefit

Locally Available Statins Simvastatin Atorvastatin Rosuvastatin Fluvastatin

Quick Info for the Different Statins StatinBrand NameManufacturer SimvastatinZocorMerck and Co. AtorvastatinLipitorPfizer RosuvastatinCrestorAstra Zeneca FluvastatinLescolZuellig All are 100% synthetic. ** Lovastatin, example of a fungus-derived stain. Not available in the Philippines.

Quick Info for the Different Statins StatinBrand Name ManufacturerClaim of Percent Lipid Lowering Effect* Nature of Source** SimvastatinZocorMerck and Co.26-47%100% Synthetic AtorvastatinLipitorPfizer26-60%100% Synthetic RosuvastatinCrestorAstra Zeneca45-63%100% Synthetic FluvastatinLescolZuellig22-36%100% Synthetic *At prescribed optimum doses. Low validity study. ** Lovastatin, example of a fungus-derived stain. Not available in the Philippines.

Simvastatin Brand name: Zocor, manufactured by Merck and Co. (Zeullig) Contains: starch, talc, cellulose, lactose, magnesium stearate, iron oxides or titanium dioxide as inactive ingredients in the drug.

Atorvastatin Brand name: Lipitor, manufactured by Pfizer. Pfizer claims that Lipitor is the most researched statin on the market. 100% synthetic, compared to other statins which are derived from fungus.

Rosuvastatin Brand name: Crestor, manufactured by AstraZeneca Claims to lower cholesterol by

Fluvastatin Brand name: Lescol, manufactured by Zuellig Also 100% synthetic

Summary Drug ClassEfficacySafetySuitabilityCost Simvastatin (Afordel, 40mg) (P 17.33/day) Atorvastatin (Lipitor, 10mg) (P 34.45/day) Rosuvastin (Crestor, 10mg) (P 57.66/day) Fluvastatin (Lescol, 40mg) (P52.61/day) Therefore, SIMVASTATIN is the best option among the statins option.

STEP 4 Prescription Writing

A.Dionisia 62Female Simvastatin, 40 mg tablet 30 Inomin 1x tuwing gabi. Dr. Manny Kalayaan Date: November 17, 2010

Manny Kalayaan, MD, FPCP, FPMID Philippine General Hospital Mon-Friday 9am to 4pm Patient: ADDate: November 17, 2010 Address: ManilaAge/Sex: 62/F R/ Simvastatin 40 mg tablet#30 Sig: Inomin 1 tablet sa gabi Dr. Manny Kalayaan Lic. No